A renaissance in trace amines inspired by a novel GPCR family

Trends in Pharmacological Sciences

Volumn 26, Issue 5, 2005, Pages 274-281

  Lindemann, Lothar ^a   Hoener, Marius C ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; AMINE; AMPHETAMINE; ETHYLAMINE; G PROTEIN COUPLED RECEPTOR; HISTAMINE; MONOAMINE OXIDASE INHIBITOR; N METHYLPHENETHYLAMINE; N METHYLTRYPTAMINE; NEUROTRANSMITTER; NORADRENALIN; OCTOPAMINE; OXEDRINE; PHENETHYLAMINE; SEROTONIN; TRYPTAMINE; TRYPTAMINE DERIVATIVE; TYRAMINE; UNCLASSIFIED DRUG;

DEPRESSION; DRUG EFFECT; DRUG METABOLISM; HUMAN; MEDICAL RESEARCH; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA;

EID: 18044365202     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.03.007     Document Type: Review

References (60)

1. A.Y. Deutch, and R.H. Roth Neurotransmitters M.J. Zigmond Fundamental Neuroscience 2nd edn 1999 Academic Press 193 234
2. M.L. Wong, and J. Licinio Research and treatment approaches to depression Nat. Rev. Neurosci. 2 2001 343 351
3. A. Carlsson Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence Annu. Rev. Pharmacol. Toxicol. 41 2001 237 260
4. P. Tuite, and J. Riss Recent developments in the pharmacological treatment of Parkinson's disease Expert Opin. Investig. Drugs 12 2003 1335 1352
5. F.X. Castellanos, and R. Tannock Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes Nat. Rev. Neurosci. 3 2002 617 628
6. E. Usdin M. Sandler Trace Amines and the brain 1984 Dekker
7. T.A. Branchek, and T.P. Blackburn Trace amine receptors as targets for novel therapeutics: legend, myth and fact Curr. Opin. Pharmacol. 3 2003 90 97
8. R.T. Premont Following the trace of elusive amines Proc. Natl. Acad. Sci. U. S. A. 98 2001 9474 9475
9. D.D. Mousseau, and R.F. Butterworth A high-affinity [3H] tryptamine binding site in human brain Prog. Brain Res. 106 1995 285 291
10. J.K. McCormack Autoradiographic localization of tryptamine binding sites in the rat and dog central nervous system J. Neurosci. 6 1986 94 101
11. L.E. Dyck Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor Life Sci. 44 1989 1149 1156
12. E.M. Parker, and L.X. Cubeddu Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding J. Pharmacol. Exp. Ther. 245 1988 199 210
13. B. Borowsky Trace amines: identification of a family of mammalian G protein-coupled receptors Proc. Natl. Acad. Sci. U. S. A. 98 2001 8966 8971
14. J.R. Bunzow Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor Mol. Pharmacol. 60 2001 1181 1188
15. L. Lindemann Trace amine associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors Genomics 85 2005 372 385
16. O. Civelli GPCR deorphanizations: the novel, the known and the unexpected transmitters Trends Pharmacol. Sci. 26 2005 15 19
17. T.S. Scanlan 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone Nat. Med. 10 2004 638 642
18. M.D. Berry Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators J. Neurochem. 90 2004 257 271
19. M.V. Olson, and A. Varki Sequencing the chimpanzee genome: insights into human evolution and disease Nat. Rev. Genet. 4 2003 20 28
20. P. Malherbe Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine Mol. Pharmacol. 64 2003 823 832
21. J.M. Saavedra β-Phenylethylamine, phenylethanolamine, tyramine and octopamine U. Trendelenburg N. Weiner Catecholamines II 1989 Springer 181 201
22. J.M. Saavedra The distribution and properties of the nonspecific N-methyltransferase in brain J. Neurochem. 20 1973 743 752
23. J.M. Saavedra Localisation of phenylethanolamine N-methyl transferase in the rat brain nuclei Nature 248 1974 695 696
24. R.S. Jones, and A.A. Boulton Tryptamine and 5-hydroxytryptamine: actions and interactions of cortical neurones in the rat Life Sci. 27 1980 1849 1856
25. R.S. Jones Tryptamine modifies cortical neurone responses evoked by stimulation of nucleus raphe medianus Brain Res. Bull. 8 1982 435 437
26. M.D. Berry The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine Br. J. Pharmacol. 113 1994 1159 1166
27. Federici, M. et al. Trace amines depress GABAB response in dopaminergic neurons by inhibiting GIRK channels. Mol. Pharmacol. DOI: 10.1124/mol.104.007427 (http://molpharm.aspetjournals.org)
28. X.M. Li Absence of 2-phenylethylamine binding after monoamine oxidase inhibition in rat brain Eur. J. Pharmacol. 210 1992 189 193
29. R.L. Hauger Specific [3H] beta-phenylethylamine binding sites in rat brain Eur. J. Pharmacol. 83 1982 147 148
30. A. Vaccari High affinity binding of [3H]-tyramine in the central nervous system Br. J. Pharmacol. 89 1986 15 25
31. T.V. Nguyen, and A.V. Juorio Binding sites for brain trace amines Cell. Mol. Neurobiol. 9 1989 297 311
32. C.S. Cascio, and K.J. Kellar Characterization of [3H] tryptamine binding sites in brain Eur. J. Pharmacol. 95 1983 31 39
33. V. Cornea-Hebert Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat J. Comp. Neurol. 409 1999 187 209
34. T.D. Sotnikova Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine J. Neurochem. 91 2004 362 373
35. C.B. Jaeger Aromatic L-amino acid decarboxylase in the rat brain: immunocytochemical localization in neurons of the brain stem Neuroscience 11 1984 691 713
36. A.P. Davenport Peptide and trace amine orphan receptors: prospects for new therapeutic targets Curr. Opin. Pharmacol. 3 2003 127 134
37. S. Shirkande Plasma phenylethylamine levels of schizophrenic patients Can. J. Psychiatry 40 1995 221
38. S.G. Potkin Phenylethylamine in paranoid chronic schizophrenia Science 206 1979 470 471
39. P.A. Janssen Does phenylethylamine act as an endogenous amphetamine in some patients? Int. J. Neuropsychopharmcol. 2 1999 229 240
40. J.D. Griffith Psychosis induced by the administration of d-amphetamine to human volunteers D.H. Efron Psychomimetic Drugs 1970 Raven 287 298
41. J.W. Lenders Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes J. Clin. Invest. 97 1996 1010 1019
42. Q. Cao Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees Genomics 43 1997 1 8
43. J. Duan Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia Am. J. Hum. Genet. 75 2004 624 638
44. K.T. Mueser, and S.R. McGurk Schizophrenia Lancet 363 2004 2063 2072
45. H.C. Sabelli, and A.D. Mosnaim Phenylethylamine hypothesis of affective behavior Am. J. Psychiatry 131 1974 695 699
46. B.A. Davis, and A.A. Boulton The trace amines and their acidic metabolites in depression - an overview Prog. Neuropsychopharmacol. Biol. Psychiatry 18 1994 17 45
47. H.C. Sabelli Sustained antidepressant effect of PEA replacement J. Neuropsychiatry Clin. Neurosci. 8 1996 168 171
48. M. Sandler Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness Clin. Chim. Acta 93 1979 169 171
49. K.M. Dewar Involvement of brain trace amines in the behavioural effects of phenelzine Neurochem. Res. 13 1988 113 119
50. J. Grimsby Increased stress response and beta-phenylethylamine in MAOB-deficient mice Nat. Genet. 17 1997 206 210
51. D. Scully Physical exercise and psychological well being: a critical review Br. J. Sports Med. 32 1998 111 120
52. A.A. Russo-Neustadt Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus Neuroscience 101 2000 305 312
53. E. Carro Brain repair and neuroprotection by serum insulin-like growth factor I Mol. Neurobiol. 27 2003 153 162
54. A. Szabo Phenylethylamine, a possible link to the antidepressant effects of exercise? Br. J. Sports Med. 35 2001 342 343
55. D.A. Durden, and S.R. Philips Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain J. Neurochem. 34 1980 1725 1732
56. M.L. Bouthenet A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I] iodobolpyramine Neuroscience 26 1988 553 600
57. H. Haas, and P. Panula The role of histamine and the tuberomamillary nucleus in the nervous system Nat. Rev. Neurosci. 4 2003 121 130
58. P. Ma, and R. Zemmel Value of novelty? Nat. Rev. Drug Discov. 1 2002 571 572
59. M. Bouvier Oligomerization of G protein-coupled transmitter receptors Nat. Rev. Neurosci. 2 2001 274 286
60. L.F. Agnati Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons Pharmacol. Rev. 55 2003 509 550